S100A4 overexpression contributed to pancreatic cancer cell perineural invasion [116] and poor clinical outcomes because of the inability of TGF-β1-mediated cell growth inhibition and apoptosis of pancreatic cancer cells. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.